Status:
COMPLETED
Post-Infectious Irritable Bowel Syndrome (PI-IBS)
Lead Sponsor:
KU Leuven
Conditions:
Irritable Bowel Syndrome With Diarrhea
Eligibility:
All Genders
18-70 years
Brief Summary
Purpose: * identification of factors predisposing for Post-Infectious Irritable Bowel Syndrome (PI-IBS) development after an episode of traveler's diarrhea * identification of systemic (serum) and lo...
Eligibility Criteria
Inclusion
- traveling to South-America, Africa, South-East Asia
- 18-70 years
- traveling for 1-10 weeks
Exclusion
- Chronic diarrhea
- Pregnant
- Colitis Ulcerosa
- Morbus Chrohn
- IBS
- Coeliakie
- Gastrointestinal malabsorption
- microscopic colitis
- diverticulitis
- immune deficiency
- use of antibiotics/corticosteroids 2 weeks before travelling
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
131 Patients enrolled
Trial Details
Trial ID
NCT01497847
Start Date
March 1 2010
End Date
February 1 2013
Last Update
April 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospitals Leuven
Leuven, Vlaams-Brabant, Belgium, 3000